Literature DB >> 9988286

Gender differences in cognitive function with age: the Rancho Bernardo study.

E Barrett-Connor1, D Kritz-Silverstein.   

Abstract

BACKGROUND: Estrogen deficiency has been proposed as a cause of memory loss in postmenopausal women. If true, men should have less memory loss with age than women. The present study is designed to examine the postulated effect of estrogen on memory by studying the effect of gender on the age-related decline in cognitive function.
METHODS: Cross-sectional study of 800 women and 551 men aged 65 to 95 years, members of the community-based Rancho Bernardo Study (begun in 1972 and 1974) who completed the Beck Depression Inventory in 1984-1987 and 12 standardized tests of cognitive function in 1988-1991. All participants were white, middle to upper-middle class, relatively well educated, and ambulatory. At all visits, use of estrogen therapy was ascertained and validated.
RESULTS: Test performance worsened with age in both sexes, with similar patterns in men compared with women who were current, past, or never users of estrogen. Between-gender comparisons of the slope for age on each cognitive function test after adjustment for education, depressed mood, and estrogen use (in women) indicated that men had a significantly steeper decrement with age than women on the Buschke total recall and long-term memory tests (P <. 001), on the immediate and delayed recall tasks of the visual reproduction tests (P < .01 and .05, respectively), and on category fluency (P < .05). Similar results were obtained when gender comparisons included only women who had never used estrogen.
CONCLUSION: These weak or absent gender differences in decline in cognitive function with age do not support the thesis that estrogen deficiency is associated with a decline in cognitive function in postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988286     DOI: 10.1111/j.1532-5415.1999.tb04573.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  17 in total

Review 1.  The role of ovarian hormones in preserving cognition in aging.

Authors:  Jeri S Janowsky
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

2.  Memory Self-Efficacy and Memory Performance in Older Males.

Authors:  Graham J McDougall; Jeonghee Kang
Journal:  Int J Mens Health       Date:  2003

3.  Education and Cognitive Decline in Older Americans: Results From the AHEAD Sample.

Authors:  Dawn Alley; Kristen Suthers; Eileen Crimmins
Journal:  Res Aging       Date:  2007-01-01

Review 4.  Sex differences in cognitive impairment in Alzheimer's disease.

Authors:  Keith R Laws; Karen Irvine; Tim M Gale
Journal:  World J Psychiatry       Date:  2016-03-22

5.  Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy.

Authors:  Erin E Sundermann; Anat Biegon; Leah H Rubin; Richard B Lipton; Wenzhu Mowrey; Susan Landau; Pauline M Maki
Journal:  Neurology       Date:  2016-03-16       Impact factor: 9.910

6.  Gender-specificities in Alzheimer's disease and mild cognitive impairment.

Authors:  U Beinhoff; H Tumani; J Brettschneider; D Bittner; M W Riepe
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

7.  Applying new research criteria for diagnosis of early Alzheimer's disease: sex and intelligence matter.

Authors:  U Beinhoff; H Tumani; M W Riepe
Journal:  Int J Alzheimers Dis       Date:  2009-08-12

8.  Plasma trace elements and cognitive function in older men and women: the Rancho Bernardo study.

Authors:  P K Lam; D Kritz-Silverstein; E Barrett Connor; D Milne; F Nielsen; A Gamst; D Morton; D Wingard
Journal:  J Nutr Health Aging       Date:  2008-01       Impact factor: 4.075

Review 9.  Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: evidence from epidemiologic studies and clinical trials.

Authors:  Elizabeth Barrett-Connor; Gail A Laughlin
Journal:  Semin Reprod Med       Date:  2009-04-28       Impact factor: 1.303

Review 10.  Postmenopausal hormone therapy: impact on menopause-related symptoms, chronic disease and quality of life.

Authors:  Marius Jan van der Mooren; Peter Kenemans
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.